Transce3nd’s Accendra Health ACH Stock Holding History

Transce3nd’s Portfolio ACH Stock Details ACH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-20	Closed	-$261	–	1461
2024 Q4	$261	Buy	+20	New	+$267	﹤0.01%	1404

Other funds holding ACH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCM

Coliseum Capital Management Rowayton, Connecticut $1.22B AUM 18.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Transce3nd's ACH Position: Q1 2025 in Review

Transce3nd sold out of Accendra Health (ACH) in Q1 2025, closing a stake of 20 shares — an estimated $261 sold.

Transce3nd first reported a position in ACH in Q4 2024 and held it in 1 quarter. The position peaked at $261 in Q4 2024. 242 funds tracked by Wall St. Rank hold ACH as of Q1 2025.

Transce3nd reported no remaining Accendra Health position as of Q1 2025 after selling out during the quarter.
Transce3nd sold 20 Accendra Health shares in Q1 2025, an estimated $261.
Transce3nd first reported a position in Accendra Health in Q4 2024 and held it in 1 quarter.
Transce3nd's Accendra Health position peaked at $261 in Q4 2024.
242 funds tracked by Wall St. Rank held Accendra Health as of Q1 2025.

Based on Transce3nd's 13F filing for Q1 2025, filed 5 May 2025.